7MM cancer cachexia market eyes 8.9% CAGR growth through 2034 | Healthcare Asia Magazine
Photo from Envato

7MM cancer cachexia market eyes 8.9% CAGR growth through 2034

Thanks to the introduction of new therapies.

The cancer cachexia market across seven major markets (7MM) is expected to expand at a compound annual growth rate of 8.9% until 2034, said DelveInsight.

The sector’s growth is driven by the emergence of new therapies, along with the rising prevalence of the condition, increasing incidence of high-risk tumour types, and improved diagnostic awareness.

Cancer cachexia, a multifactorial wasting disorder observed in advanced stages of cancer, is characterised by a progressive depletion of skeletal muscle and fat.

“Potential therapies are being investigated for the treatment of cancer cachexia, and it is safe to predict that the treatment space will significantly impact the cancer cachexia market during the forecast period,” the report said.

7MM = US, Germany, France, Italy, Spain, UK, and Japan.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!